Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development.
Aditya H Gaur, John C Panetta, Amber M Smith, Ronald H Dallas, Burgess B Freeman, Tracy B Stewart, Li Tang, Elizabeth John, Kristen C Branum, Nehali D Patel, Shelley Ost, Ryan N Heine, Julie L Richardson, Jared T Hammill, Lidiya Bebrevska, Fabian Gusovsky, Noritsugu Maki, Toshiharu Yanagi, Patricia M Flynn, James S McCarthy, Stephan Chalon, R Kiplin Guy
EBioMedicine 2022;80():104065